MD4865C1 - Utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei în tratamentul simptomelor negative primare ale schizofreniei - Google Patents

Utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei în tratamentul simptomelor negative primare ale schizofreniei

Info

Publication number
MD4865C1
MD4865C1 MDA20150058A MD20150058A MD4865C1 MD 4865 C1 MD4865 C1 MD 4865C1 MD A20150058 A MDA20150058 A MD A20150058A MD 20150058 A MD20150058 A MD 20150058A MD 4865 C1 MD4865 C1 MD 4865C1
Authority
MD
Moldova
Prior art keywords
dimethylcarbamoyl
cyclohexylamine
piperazin
schizophrenia
dichlorophenyl
Prior art date
Application number
MDA20150058A
Other languages
English (en)
Russian (ru)
Other versions
MD20150058A2 (ro
MD4865B1 (ro
Inventor
Янош Гиёрги ПИТТЕР
Балаж Сатмари
Марк ДЕБЕЙ
Гиёрги Йожеф НЕМЕТ
Истван ЛАСЛОВСКИ
Original Assignee
Richter Gedeon Nyrt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt. filed Critical Richter Gedeon Nyrt.
Publication of MD20150058A2 publication Critical patent/MD20150058A2/ro
Publication of MD4865B1 publication Critical patent/MD4865B1/ro
Publication of MD4865C1 publication Critical patent/MD4865C1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-l-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei (cariprazinei) şi sărurilor farmaceutic acceptabile, hidraţilor, solvaţilor şi formelor polimorfe ale acesteia în tratamentul simptomelor negative primare ale schizofreniei.
MDA20150058A 2012-11-29 2013-11-28 Utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei în tratamentul simptomelor negative primare ale schizofreniei MD4865C1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1200691A HU231227B1 (hu) 2012-11-29 2012-11-29 Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére
PCT/IB2013/060465 WO2014083522A1 (en) 2012-11-29 2013-11-28 Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia

Publications (3)

Publication Number Publication Date
MD20150058A2 MD20150058A2 (ro) 2015-11-30
MD4865B1 MD4865B1 (ro) 2023-07-31
MD4865C1 true MD4865C1 (ro) 2024-02-29

Family

ID=70289034

Family Applications (2)

Application Number Title Priority Date Filing Date
MDA20150058A MD4865C1 (ro) 2012-11-29 2013-11-28 Utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei în tratamentul simptomelor negative primare ale schizofreniei
MDA20200089A MD20200089A2 (ro) 2012-11-29 2013-11-28 Trans-4-{2-[4-(2,3- diclorofenil)-piperazin-1- il]-etil}-N,N- dimetilcarbamoil- ciclohexilamină pentru tratamentul simptomelor negative ale schizofreniei

Family Applications After (1)

Application Number Title Priority Date Filing Date
MDA20200089A MD20200089A2 (ro) 2012-11-29 2013-11-28 Trans-4-{2-[4-(2,3- diclorofenil)-piperazin-1- il]-etil}-N,N- dimetilcarbamoil- ciclohexilamină pentru tratamentul simptomelor negative ale schizofreniei

Country Status (36)

Country Link
US (1) US20150306094A1 (ro)
EP (2) EP2925324B1 (ro)
JP (2) JP2016501215A (ro)
KR (2) KR20210010955A (ro)
CN (1) CN104812390A (ro)
AP (1) AP2015008448A0 (ro)
AU (1) AU2013350819B9 (ro)
BR (1) BR112015012512A2 (ro)
CA (1) CA2890952A1 (ro)
CL (1) CL2015001468A1 (ro)
CR (1) CR20150244A (ro)
CY (1) CY1123766T1 (ro)
DK (1) DK2925324T3 (ro)
EA (1) EA039245B1 (ro)
ES (1) ES2863052T3 (ro)
GE (1) GEP20186849B (ro)
HK (1) HK1212608A1 (ro)
HR (1) HRP20210486T1 (ro)
HU (2) HU231227B1 (ro)
IL (1) IL238723B (ro)
LT (1) LT2925324T (ro)
MD (2) MD4865C1 (ro)
MX (2) MX2015006677A (ro)
MY (1) MY174663A (ro)
NI (1) NI201500074A (ro)
NZ (1) NZ708295A (ro)
PE (1) PE20151052A1 (ro)
PH (1) PH12015501124B1 (ro)
PL (1) PL2925324T3 (ro)
PT (1) PT2925324T (ro)
RS (1) RS61509B1 (ro)
SG (1) SG11201503672SA (ro)
SI (1) SI2925324T1 (ro)
UA (1) UA123492C2 (ro)
WO (1) WO2014083522A1 (ro)
ZA (1) ZA201503660B (ro)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG192507A1 (en) 2008-07-16 2013-08-30 Richter Gedeon Nyrt Pharmaceutical formulations containing dopamine receptor ligands
CN105218484B (zh) * 2015-09-14 2018-02-23 安徽省逸欣铭医药科技有限公司 酒石酸卡利拉嗪及其制备方法和医药用途
HU231173B1 (hu) * 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
WO2019016828A1 (en) * 2017-07-15 2019-01-24 Msn Laboratories Private Limited, R&D Center NOVEL PROCESSES FOR THE PREPARATION OF TRANS-N- {4- [2- [4- (2,3-DICHLOROPHENYL) PIPERAZIN-1-YL] ETHYL] CYCLOHEXYL} -N ', N'-DIMETHYLUMED HYDROCHLORIDE AND POLYMORPHS THIS ONE
US20200375983A1 (en) * 2017-12-01 2020-12-03 Aurobindo Pharma Ltd A process for the preparation of cariprazine hydrochloride
WO2020056929A1 (zh) * 2018-09-21 2020-03-26 上海诚妙医药科技有限公司 卡利拉嗪盐酸盐的新晶型及其制备方法及其用途
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
US11344503B2 (en) 2019-12-13 2022-05-31 Halo Science LLC Cariprazine release formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227534B1 (en) 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
HU230748B1 (hu) 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása
HUP0700369A2 (en) 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia
KR20100022955A (ko) * 2007-05-24 2010-03-03 리히터 게데온 닐트. (티오) -카르바모일-시클로헥산 유도체 및 정신분열 치료 방법
WO2010126527A1 (en) 2009-05-01 2010-11-04 Forest Laboratories Holdings Limited Methods of treating cns disorders

Also Published As

Publication number Publication date
US20150306094A1 (en) 2015-10-29
AP2015008448A0 (en) 2015-05-31
KR102314248B1 (ko) 2021-10-19
HRP20210486T1 (hr) 2021-05-14
KR20150088270A (ko) 2015-07-31
JP2019163240A (ja) 2019-09-26
EA201500575A1 (ru) 2015-09-30
CY1123766T1 (el) 2022-05-27
PE20151052A1 (es) 2015-08-09
JP2016501215A (ja) 2016-01-18
HUE054054T2 (hu) 2021-08-30
PL2925324T3 (pl) 2021-06-28
GEP20186849B (en) 2018-05-10
HUP1200691A1 (ro) 2014-06-30
MX2015006677A (es) 2015-08-10
EP3653211A1 (en) 2020-05-20
MX2021000342A (es) 2021-04-13
NZ708295A (en) 2020-03-27
CA2890952A1 (en) 2014-06-05
SI2925324T1 (sl) 2021-04-30
ES2863052T3 (es) 2021-10-08
EA039245B1 (ru) 2021-12-22
AU2013350819B9 (en) 2018-06-21
UA123492C2 (uk) 2021-04-14
HK1212608A1 (zh) 2016-06-17
MD20150058A2 (ro) 2015-11-30
PT2925324T (pt) 2021-02-16
IL238723B (en) 2020-02-27
WO2014083522A1 (en) 2014-06-05
PH12015501124A1 (en) 2015-08-03
CR20150244A (es) 2015-06-23
AU2013350819B2 (en) 2018-05-31
NI201500074A (es) 2015-09-18
HU231227B1 (hu) 2022-03-28
EP2925324A1 (en) 2015-10-07
MD4865B1 (ro) 2023-07-31
MD20200089A2 (ro) 2021-05-31
AU2013350819A1 (en) 2015-06-04
EP2925324B1 (en) 2020-12-30
DK2925324T3 (da) 2021-03-01
CN104812390A (zh) 2015-07-29
IL238723A0 (en) 2015-06-30
RS61509B1 (sr) 2021-03-31
ZA201503660B (en) 2016-03-30
SG11201503672SA (en) 2015-06-29
LT2925324T (lt) 2021-02-25
BR112015012512A2 (pt) 2017-07-11
MY174663A (en) 2020-05-05
KR20210010955A (ko) 2021-01-28
PH12015501124B1 (en) 2015-08-03
CL2015001468A1 (es) 2015-08-07

Similar Documents

Publication Publication Date Title
MD4865C1 (ro) Utilizarea trans-4-{2-[4-(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilaminei în tratamentul simptomelor negative primare ale schizofreniei
PH12016502081A1 (en) Compounds for treating spinal muscular atrophy
AU2014267235A8 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
TN2014000158A1 (en) Fused bicyclic oxazolidinone cetp inhibitor
TW201613872A (en) IRAK4 inhibiting agents
MA39749A (fr) Dérivés de pipéridine-dione
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
MA40170A (fr) Dérivés hétérocycliques de morphinan et leur utilisation
GEP20135730B (en) Trans-4-{2-[4-(2,3-dichlorophe-nyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treatment of schizophrenia
GB201209587D0 (en) Therapeutic compounds
TR201900735T4 (tr) Yeni kaynaşık imidazobenzotiyazol bileşikleri.
IN2013MU03862A (ro)
EA201391793A1 (ru) Новый способ синтеза 7-хлор-4-(пиперазин-1-ил)-хинолина
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
IN2013MU02010A (ro)

Legal Events

Date Code Title Description
FG4A Patent for invention issued